SALT LAKE CITY, March 31, 2021 /PRNewswire/ — The CEO of Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, appeared yesterday on Yahoo! Finance to comment on the Company’s recently-released FY2020 earnings report, and to discuss its going-forward strategy as the world struggles to achieve normalization.
Co-Diagnostics CEO Dwight Egan remarked, “We believe that the future of gold-standard PCR…
Source link
